Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipid-transporting ATPase VD (ATP10D) is a member of the P4-ATPase family, functioning as the catalytic core of a flippase complex that hydrolyzes ATP to drive the translocation of glucosylceramide and other aminophospholipids across cellular membranes, thereby maintaining membrane lipid asymmetry[6][7][1]. ATP10D is expressed in multiple tissues and localizes to the endoplasmic reticulum, nucleoplasm, and plasma membrane[1][2]. Although the full physiological and pathological significance of ATP10D in humans is still under investigation, genetic association studies suggest a role for ATP10D in lipid metabolism and cardiometabolic disorders[5]. Presently, there are no drugs known to directly target this protein, and it is not widely used as a biomarker or therapeutic target in current clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipid-transporting ATPase VD (ATP10D).